Home | Welcome to Contract Pharma   
Last Updated Tuesday, May 21 2013
Print RSS Feed

Breaking News

Related Searches: Promotions & Moves •
Metrics, Inc.

August 25, 2008
Dr. Michael D. Ruff has recently been appointed vice president of pharmaceutical development at Metrics, Inc. He recently received his clinical doctor of pharmacy degree from the Shenandoah University Bernard J. Dunn College of Pharmacy. Dr. Ruff…  Read More »
FDA Approves Amgen's Nplate

August 25, 2008
The FDA has approved Amgen's Nplate, the first and only platelet producer for the treatment of thrombocytopenia in splenectomized (spleen removed) and non-splenectomized adults with chronic immune thrombocytopenic purpura (ITP). Nplate, the first FDA…  Read More »
AAIPharma

August 25, 2008
Scott Neilson has been appointed to the position of chief operating officer of AAIPharma. Mr. Neilson will be responsible for the company's global drug development services operations, reporting to chief executive officer and president Dr. Ludo Reynd…  Read More »
Sancilio Expands Manufacturing Facility

August 22, 2008
Sancilio & Company, Inc. (SCI) opened its newly expanded 2,000-sq.-ft. contract manufacturing facility. The GMP facility specializes in small batch manufacturing of tablets and capsules as well as packaging and labeling services.  &nb…  Read More »
CDC To Implement Pilgrim's Compliance Software

August 22, 2008
The Centers for Disease Control and Prevention (CDC) will implement Pilgrim Software's automated platform for document control, complaints and corrective and preventive action (CAPA) systems management throughout the Laboratory Response Network (LRN)…  Read More »
Biogen Idec Begins Phase III Adentri Trial

August 22, 2008
Biogen Idec initiated a Phase III trial of intravenous (IV) Adentri (BG9928), an adenosine A1 receptor antagonist for acute decompensated heart failure (ADHF) patients with renal insufficiency. The trial will evaluate Adentri — developed under…  Read More »
Boehringer Extends Alzheimer's Pact with Ablynx

August 21, 2008
Boehringer Ingelheim has extended research funding for another year in its Alzheimer's disease collaboration with Ablynx. In January 2007 the companies entered into a $265 million worldwide research and licensing agreement to discover and develop new…  Read More »
Bayer, Onyx Begin Enrollment in STORM Trial

August 21, 2008
Bayer HealthCare Pharmaceuticals and Onyx Pharmaceuticals began enrolling patients in the STORM (Sorafenib as Adjuvant Treatment in the Prevention of Recurrence of Hepatocellular Carcinoma) trial. The randomized, double-blind, placebo-controlled Phas…  Read More »
Octagon Research Solutions

August 21, 2008
Lex Jansen has been appointed senior consultant, Clinical Data Strategies, Octagon Research Solutions. In his new role, Mr. Jansen will serve as a consultant on Clinical Data Interchange Standard Consortium (CDISC) Study Data Tabulation Model (SDTM)…  Read More »
BMS, PDL BioPharma Enter Multiple Myeloma Drug Pact

August 20, 2008
Bristol-Myers Squibb and PDL BioPharma, Inc. entered an agreement for the global development and commercialization of PDL’s anti-CS1 antibody, elotuzumab, currently in Phase I development for multiple myeloma.     Elotuzumab o…  Read More »
Sepracor

August 20, 2008
Richard Ranieri has been appointed to the newly created position of executive vice president, Human Resources and Administration, and Julio Casoy, M.D. has been appointed senior vice president, Medical Affairs, at Sepracor.     Mr.…  Read More »
United Drug Acquires Sharp Corp.

August 20, 2008
United Drug plc, an Ireland-based distributor, wholesaler and contract packager, has acquired Allentown, PA-based Sharp Corporation for $99 million. The acquisition is intended to complement UD's contract packaging operations in Europe with Sharp's U…  Read More »
Averion International

August 19, 2008
Peter C. Gonze has been appointed executive vice president of Global Business Development at Averion International Corp. In this role, he will oversee the company’s global business development and marketing activities, and will serve on the com…  Read More »
Cellumen, Mitsubishi Tanabe Enter Tox Pact

August 19, 2008
Cellumen, Inc., a discovery toxicology company, entered an agreement with Mitsubishi Tanabe Pharma Corp. (MTPC), to develop panels of biomarkers that identify toxicity early in the drug development process.     “We’re pl…  Read More »
Emisphere Technologies

August 19, 2008
Nicholas J. Hart has joined Emisphere Technologies, Inc. as vice president of strategy and development. In this capacity, Mr. Hart will be responsible for the planning and commercial development aspects of the company's Eligen technology.  &nbs…  Read More »

Receive free Contract Pharma Direct emails
Sign up now to receive the weekly newsletter, and more!

Enter your email address:

Follow Contract Pharma On
Please visit our sister sites: